Author

ChaoYu Jin

AstraZeneca (United Kingdom)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

Anton I. RosenbaumiD· 1 shared B. Timothy HummeriD· 1 shared Joseph S. GrimsbyiD· 1 shared Kristina S. KovacinaiD· 1 shared Meina LiangiD· 1 shared Ruipeng Mu· 1 shared Yue HuangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Anton I. RosenbaumORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of Endothelial Lipase by MEDI5884 Normalizes Phosphatidylinositol Levels in Coronary Artery Disease Patients

Anton I. Rosenbaum, Yue Huang, Ruipeng Mu, Kristina S. Kovacina, ChaoYu Jin, B. Timothy Hummer, Meina Liang, Joseph S. Grimsby

This study shows that MEDI5884 increases phosphatidylinositol levels in CAD patients by inhibiting endothelial lipase, correlating with improved HDL function and reverse cholesterol transport.

bioRxiv · May 30, 2024 · PreprintPharmacology & Toxicology